Cardil tablet launched for treatment of high blood pressure and benign prostatic hyperplasia
KyungDong Pharm launched Cardil tablets in October 2000, which are effective in treating both high blood pressure and symptoms of benign prostatic hyperplasia.
Cardil has a continuous blood pressure lowering effect when administered once a day, and has the effect of improving mild lipid metabolism and the risk of coronary heart disease, making it safer and more effective for patients with frequent complications.
In addition, it is a product that provides rapid improvement and provides excellent satisfaction to patients who have difficulty urinating due to benign prostatic hyperplasia.
| Cardil Jung |
|
● Ingredients/Content 1 politeness Doxazosin mesylate 2.43mg (2mg as doxazosin)
●Efficacy/Effectiveness Hypertension, urinary obstruction and urinary dysfunction due to benign prostate hypertrophy
●Usage/Dosage 1. High blood pressure: The initial dose is 1/2 tablet once a day. Depending on the patient's response, the dose can be increased to 1 tablet after 1 week. The dose can be slowly increased to 2, 4, or 8 tablets per day at 1-2 week intervals. 2. Urinary obstruction and urination disorder due to benign prostatic hyperplasia: The initial dose is 1/2 tablet once a day. Depending on the patient's blood pressure status, the dose can be increased to 1 tablet every 1-2 weeks and gradually administered up to 2 tablets and up to 4 tablets.
●Packing unit 100 tablets, 300 tablets |